Non-Hodgkin lymphoma (NHL) consists of many histologically and biologically distinct
lymphoid malignancies with poorly understood, but possibly distinct, etiologies. The patterns …

The etiology of non-Hodgkin lymphoma, as well as its global dramatic rise in incidence
during the past decades, remains largely unexplained. However, there is increasing …

Non-Hodgkin lymphoma (NHL) comprises numerous biologically and clinically
heterogeneous subtypes, with limited data examining the risk factors for these distinct …

Introduction: Despite decades of intensive research, non-Hodgkin's Lymphoma (NHL)
remains poorly understood and is largely incurable. NHL is a heterogeneous group of …

The incidence of non-Hodgkin's lymphoma (NHL) has doubled over the past two decades in
the US and most other westernized countries. While improved cancer reporting, changes in …

Non-Hodgkin lymphoma (NHL) includes a group of more than 20 different malignant
lymphoproliferative diseases that originate from lymphocytes. Rates of NHL have increased …

The incidence of non-Hodgkin's lymphoma (NHL) has increased approximately 80% since
the 1970s, and is now the fifth most common cancer in the United States. The incidence of …

Abstract Background Non-Hodgkin lymphoma (NHL), the most common hematologic
malignancy, consists of numerous subtypes. The etiology of NHL is incompletely …

While for most cancers incidence and mortality are decreasing, those of non-Hodgkin's
lymphoma (NHL) are steadily increasing. Research to define reasons for this increase is …

The incidence rates of non‐Hodgkin lymphoma (NHL) have steadily increased over the last
several decades in the United States, and the temporal trends in incidence can only be …